AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22538275 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultracision knife
Number of subjects: 5
Study 22538275 — intervention group
Group type: COMPARATOR
Intervention: Conventional Metzenbaum-type scissors and surgical knife
Number of subjects: 5
Study 20186436 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.1 microg kg(‐1) min(‐1)
Number of subjects: 60
Study 20186436 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.2 microg kg(‐1) min(‐1)
Number of subjects: 60
Study 20186436 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.5 microg kg(‐1) min(‐1)
Number of subjects: 60
Study 18556898 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory integration therapy program
Number of subjects: 30
Study 18556898 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 30
Study 16013898 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil up to 200 mg a day (N = 13)
Number of subjects: 24
Study 16013898 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 11)
Number of subjects: 24
Study 16013898 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (N = 10)
Number of subjects: 24
Study 16013898 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N = 10)
Number of subjects: 24
Study 11889331 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials reporting mortality as the primary outcome
Number of subjects: 74
Study 11889331 — intervention group
Group type: COMPARATOR
Intervention: Trials focusing on surrogate outcome measures
Number of subjects: 74
Study 11889331 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality outcome trials
Number of subjects: 74
Study 11889331 — intervention group
Group type: COMPARATOR
Intervention: Surrogate outcome trials
Number of subjects: 74
Study 11889331 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall trial methodology
Number of subjects: 74
Study 10431093 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic appendicectomy (LA)
Number of subjects: 0
Study 10431093 — intervention group
Group type: COMPARATOR
Intervention: Open appendicectomy (OA)
Number of subjects: 0
Study 8640151 — intervention group
Group type: EXPERIMENTAL
Intervention: Ribomunyl
Number of subjects: 14
Study 2125658 — intervention group
Group type: EXPERIMENTAL
Intervention: Bismuth salicylate
Number of subjects: 52
Study 2125658 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 356235 — intervention group
Group type: EXPERIMENTAL
Intervention: Proquazone
Number of subjects: 18
Study 356235 — intervention group
Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 18
Study 31184792 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive education in the format of mind maps
Number of subjects: 136
Study 31184792 — intervention group
Group type: COMPARATOR
Intervention: Conventional education
Number of subjects: 136
Study 27993433 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular care plus self-management intervention (education, motivational interviewing, coaching, self-monitoring of BP and sodium)
Number of subjects: 138
Study 27993433 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular care plus self-management intervention
Number of subjects: 138
Study 27993433 — intervention group
Group type: COMPARATOR
Intervention: Regular care only (Control)
Number of subjects: 138
Study 25842396 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomized lidocaine administered via intranasal mucosal delivery device
Number of subjects: 0
Study 25842396 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomized lidocaine
Number of subjects: 0
Study 23973186 — intervention group
Group type: EXPERIMENTAL
Intervention: Abiraterone acetate
Number of subjects: 1195
Study 23973186 — intervention group
Group type: COMPARATOR
Intervention: Prednisone
Number of subjects: 1195
Study 20497775 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-g dose of oligofructose
Number of subjects: 26
Study 20497775 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-g dose of oligofructose
Number of subjects: 26
Study 20497775 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-g dose of native inulin
Number of subjects: 26
Study 20497775 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-g dose of native inulin
Number of subjects: 26
Study 20497775 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 18565489 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal analgesia
Number of subjects: 1756
Study 18565489 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal analgesia
Number of subjects: 1756
Study 18565489 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing levels of pain
Number of subjects: 1756
Study 16176615 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG-caffeine mixtures (200 mg caffeine and variable doses of EGCG: 90, 200, 300, or 400 mg)
Number of subjects: 14
Study 16176615 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG-caffeine mixtures
Number of subjects: 14
Study 16176615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 12949316 — intervention group
Group type: EXPERIMENTAL
Intervention: NFV 30 mg/kg TID
Number of subjects: 51
Study 12949316 — intervention group
Group type: EXPERIMENTAL
Intervention: NFV 55 mg/kg BID
Number of subjects: 51
Study 10755203 — intervention group
Group type: EXPERIMENTAL
Intervention: Celiprolol (200‐400 mg daily)
Number of subjects: 169
Study 10755203 — intervention group
Group type: COMPARATOR
Intervention: Control group (unchanged therapy)
Number of subjects: 169
Study 9063232 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement
Number of subjects: 159
Study 9063232 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite with a dentinal bonding agent
Number of subjects: 159
Study 9063232 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminate (sandwich) restoration
Number of subjects: 159
Study 2066840 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with 2.2 gm protein/100 kcal
Number of subjects: 3
Study 2066840 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with 2.7 gm protein/100 kcal
Number of subjects: 3
Study 2066840 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula with 3.2 gm protein/100 kcal
Number of subjects: 3
Study 6348986 — intervention group
Group type: EXPERIMENTAL
Intervention: 45% BCAA solution
Number of subjects: 8
Study 6348986 — intervention group
Group type: COMPARATOR
Intervention: 25% BCAA solution
Number of subjects: 8
Study 29467087 — intervention group
Group type: EXPERIMENTAL
Intervention: New disposable device for ultrasound-guided internal jugular vein cannulation
Number of subjects: 88
Study 29467087 — intervention group
Group type: COMPARATOR
Intervention: Standard ultrasound-guided approach without the device
Number of subjects: 88
Study 27706046 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based exercise training (e-training) for pwMS, 1×/week aerobic and 2×/week strength training for six months
Number of subjects: 126
Study 27706046 — intervention group
Group type: COMPARATOR
Intervention: Internet-based exercise training (e-training) for pwMS
Number of subjects: 126
Study 24656700 — intervention group
Group type: EXPERIMENTAL
Intervention: Diane-35
Number of subjects: 76
Study 24656700 — intervention group
Group type: COMPARATOR
Intervention: MPA
Number of subjects: 76
Study 23647761 — intervention group
Group type: EXPERIMENTAL
Intervention: SEMS followed by brachytherapy, 8 Gy×3
Number of subjects: 41
Study 23647761 — intervention group
Group type: COMPARATOR
Intervention: brachytherapy alone, 8 Gy×3
Number of subjects: 41
Study 21655317 — intervention group
Group type: EXPERIMENTAL
Intervention: Subsidized artemether-lumefantrine (AL) provided through retail outlets
Number of subjects: 2749
Study 21655317 — intervention group
Group type: COMPARATOR
Intervention: Control group (no subsidized AL)
Number of subjects: 2749
Study 21655317 — intervention group
Group type: COMPARATOR
Intervention: Comparison between intervention and control
Number of subjects: 2749
Study 21655317 — intervention group
Group type: COMPARATOR
Intervention: Caregivers seeking treatment for child's fever
Number of subjects: 2749
Study 21655317 — intervention group
Group type: COMPARATOR
Intervention: Child's adherence to AL
Number of subjects: 2749
Study 19099786 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochloride valacyclovir
Number of subjects: 260
Study 19099786 — intervention group
Group type: COMPARATOR
Intervention: Ribavirin
Number of subjects: 260
Study 16752333 — intervention group
Group type: COMPARATOR
Intervention: OTW in-stent occlusive (3 x 3 min.) BMSC delivery
Number of subjects: 11
Study 16752333 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell infusion via a perfusion catheter with multiple side holes (SH-PC)
Number of subjects: 11
Study 12456508 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT test pooled, leukoreduced platelet components (311 transfusions)
Number of subjects: 103
Study 12456508 — intervention group
Group type: COMPARATOR
Intervention: Conventional reference pooled, leukoreduced platelet components (256 transfusions)
Number of subjects: 103
Study 12456508 — intervention group
Group type: EXPERIMENTAL
Intervention: PCT test pooled, leukoreduced platelet components
Number of subjects: 103
Study 12456508 — intervention group
Group type: COMPARATOR
Intervention: Conventional reference pooled, leukoreduced platelet components
Number of subjects: 103
Study 10983907 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA) implemented by a Mobile Geriatric Assessment Team (MGAT) for 3 months
Number of subjects: 182
Study 10983907 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 182
Study 10983907 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Geriatric Assessment (CGA)
Number of subjects: 182
Study 8852913 — intervention group
Group type: EXPERIMENTAL
Intervention: Education group (E) - received instructions about protective behaviors and risky behaviors to avoid, provided with disposable diapers, liquid soap, and latex gloves.
Number of subjects: 42
Study 8852913 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence and education group (A) - received social reinforcement for adherence and problem solving in addition to education.
Number of subjects: 42
Study 8852913 — intervention group
Group type: COMPARATOR
Intervention: Control group (C) - received no intervention.
Number of subjects: 42
Study 8852913 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant women - received an intervention equivalent to that of the education group.
Number of subjects: 42
Study 1518701 — intervention group
Group type: EXPERIMENTAL
Intervention: IVF children
Number of subjects: 116
Study 1518701 — intervention group
Group type: COMPARATOR
Intervention: Twins and triplets (IVF and controls)
Number of subjects: 116
Study 6734072 — intervention group
Group type: COMPARATOR
Intervention: Intravenous hydrocortisone
Number of subjects: 16
Study 6734072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal hydrocortisone (100 mg/l)
Number of subjects: 16
Study 6734072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal hydrocortisone (10 mg/l and 30 mg/l) followed by intravenous hydrocortisone
Number of subjects: 16
Study 6734072 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraluminal hydrocortisone (100 mg/l) perfused with fructose and bicarbonate
Number of subjects: 16
Study 31160222 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to music played three times a day for 3 days postoperatively
Number of subjects: 0
Study 30321852 — intervention group
Group type: COMPARATOR
Intervention: Rigid boot with heel wedges
Number of subjects: 29
Study 30321852 — intervention group
Group type: EXPERIMENTAL
Intervention: Equinus cast
Number of subjects: 29
Study 28033276 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic bladder irrigation device
Number of subjects: 146
Study 28033276 — intervention group
Group type: COMPARATOR
Intervention: Traditional bladder irrigation
Number of subjects: 146
Study 25227544 — intervention group
Group type: EXPERIMENTAL
Intervention: Position two wheelchair configuration (no seat slope, solid backrest mounted at 95 degree seat to back angle, solid seat insert with flat foam cushion)
Number of subjects: 19
Study 25227544 — intervention group
Group type: COMPARATOR
Intervention: Position one wheelchair configuration (one inch of seat slope, solid backrest mounted at 105 degree seat to back angle, no solid seat insert with gel/foam contoured cushion)
Number of subjects: 19
Study 21868411 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroscopy plus electrophysiological mapping (F + EP)
Number of subjects: 156
Study 21868411 — intervention group
Group type: COMPARATOR
Intervention: Standard fluoroscopy (F)
Number of subjects: 156
Study 20083751 — intervention group
Group type: EXPERIMENTAL
Intervention: LC+LCBDE
Number of subjects: 122
Study 17907481 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing 5000 ppm fluoride (Duraphat)
Number of subjects: 30
Study 17907481 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice containing 1450 ppm fluoride (Caries Protection, control)
Number of subjects: 30
Study 15738009 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol (0.25 microg intravaginally)
Number of subjects: 84
Study 15738009 — intervention group
Group type: COMPARATOR
Intervention: Dinoprostone (0.5 mg intracervically)
Number of subjects: 84
Study 12941196 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoreductive nephrectomy
Number of subjects: 0
Study 12941196 — intervention group
Group type: COMPARATOR
Intervention: Systemic immunotherapy
Number of subjects: 0
Study 12941196 — intervention group
Group type: COMPARATOR
Intervention: Tumor embolization
Number of subjects: 0
Study 10912884 — intervention group
Group type: EXPERIMENTAL
Intervention: BCAA supplementation
Number of subjects: 12
Study 10912884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8836642 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized exercise challenge
Number of subjects: 17
Study 8836642 — intervention group
Group type: COMPARATOR
Intervention: Histamine challenge
Number of subjects: 17
Study 8836642 — intervention group
Group type: COMPARATOR
Intervention: Baseline lung function measurement without any challenge
Number of subjects: 17
Study 1718243 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% sodium chloride/dextran 70 (HSD)
Number of subjects: 166
Study 1718243 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringer's solution
Number of subjects: 166
Study 6981575 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (continuous oral administration, dosage reducing heart rate by 25%)
Number of subjects: 0
Study 6981575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31296586 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine, starting at 12 mg/day, titrated up to a maximum of 48 mg/day (36 mg/day for patients on strong CYP2D6 inhibitors).
Number of subjects: 343
Study 31296586 — intervention group
Group type: EXPERIMENTAL
Intervention: Deutetrabenazine
Number of subjects: 343
Study 29862280 — intervention group
Group type: EXPERIMENTAL
Intervention: Programmed Intermittent Epidural Bolus (PIEB)
Number of subjects: 57
Study 29862280 — intervention group
Group type: COMPARATOR
Intervention: Continuous Epidural Infusion (CEI)
Number of subjects: 57
Study 27255156 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill-integrated ankle robotics
Number of subjects: 26
Study 27255156 — intervention group
Group type: COMPARATOR
Intervention: Seated ankle robotics
Number of subjects: 26
Study 24952685 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal LV lead position (n = 202)
Number of subjects: 250
Study 24952685 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal LV lead position
Number of subjects: 250
Study 24952685 — intervention group
Group type: COMPARATOR
Intervention: Suboptimal LV lead placement
Number of subjects: 250
Study 22617579 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene citrate
Number of subjects: 626
Study 22617579 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 626
Study 22617579 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination (clomiphene citrate and metformin)
Number of subjects: 626
Study 22617579 — intervention group
Group type: COMPARATOR
Intervention: Control (non-ovulating women)
Number of subjects: 626
Study 20650012 — intervention group
Group type: EXPERIMENTAL
Intervention: time‐contingent paracetamol (4 g daily in divided doses)
Number of subjects: 1650
Study 20650012 — intervention group
Group type: EXPERIMENTAL
Intervention: PRN paracetamol
Number of subjects: 1650
Study 20650012 — intervention group
Group type: COMPARATOR
Intervention: double placebo
Number of subjects: 1650
Study 17993030 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamide peroxide containing dentifrice (Rembrandt Plus)
Number of subjects: 30
Study 17993030 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride containing dentifrice (Close Up with fluoride)
Number of subjects: 30
Study 17993030 — intervention group
Group type: COMPARATOR
Intervention: Artificial saliva (control group)
Number of subjects: 30
Study 15848538 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cessation of corticosteroid therapy
Number of subjects: 397
Study 15848538 — intervention group
Group type: COMPARATOR
Intervention: Long-term corticosteroid maintenance therapy
Number of subjects: 397
Study 15848538 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus-based immunosuppressive regimen
Number of subjects: 397
Study 11889372 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleproctored endoscopic sinus surgery
Number of subjects: 87
Study 11889372 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic sinus surgery (control)
Number of subjects: 87
Study 9785195 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH‐a/hMG
Number of subjects: 198
Study 9785195 — intervention group
Group type: COMPARATOR
Intervention: hMG-only
Number of subjects: 198
Study 7622004 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy aimed at maintaining near-normal blood glucose values
Number of subjects: 0
Study 7622004 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment regimen
Number of subjects: 0
Study 7622004 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive therapy
Number of subjects: 0
Study 7622004 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 0
Study 7622004 — intervention group
Group type: EXPERIMENTAL
Intervention: Total glycemic exposure
Number of subjects: 0
Study 7622004 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-DCCT glycemic exposure (screening HbA1c value and IDDM duration)
Number of subjects: 0
Study 7622004 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycemic exposure during the DCCT (mean HbA1c, time in study)
Number of subjects: 0
Study 2143145 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting GnRH-a administered in early follicular phase (group A)
Number of subjects: 216
Study 2143145 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-acting GnRH-a administered in midluteal phase (group B)
Number of subjects: 216
Study 2143145 — intervention group
Group type: COMPARATOR
Intervention: Both groups A and B
Number of subjects: 216
Study 735925 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (single dose)
Number of subjects: 23
Study 735925 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (long-term treatment)
Number of subjects: 23
Study 735925 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (sustained treatment for 6 months)
Number of subjects: 23
Study 735925 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine (sustained treatment for 6 to 36 months)
Number of subjects: 23
Study 735925 — intervention group
Group type: COMPARATOR
Intervention: Methylscopolamine (control)
Number of subjects: 23
Study 30796832 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative denosumab
Number of subjects: 106
Study 28926440 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 0 μg/ml
Number of subjects: 345
Study 28926440 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 1 μg/ml
Number of subjects: 345
Study 28926440 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural fentanyl 2 μg/ml
Number of subjects: 345
Study 28926440 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative fentanyl dose
Number of subjects: 345
Study 25060423 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking
Number of subjects: 42
Study 25060423 — intervention group
Group type: COMPARATOR
Intervention: Control group (no facilitated tucking)
Number of subjects: 42
Study 23415422 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 1%
Number of subjects: 24
Study 23415422 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoroquinolone (gatifloxacin 0.3%, moxifloxacin 0.5%, ofloxacin 0.3%)
Number of subjects: 24
Study 23415422 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated fellow eye)
Number of subjects: 24
Study 20632302 — intervention group
Group type: COMPARATOR
Intervention: Infrapatellar taping
Number of subjects: 41
Study 20632302 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps strengthening
Number of subjects: 41
Study 20632302 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps stretching
Number of subjects: 41
Study 20632302 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study 20632302 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatments (taping, strengthening, stretching)
Number of subjects: 41
Study 19589154 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient supplementation
Number of subjects: 1420
Study 19589154 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake assessment using FFQ
Number of subjects: 1420
Study 17144784 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 0
Study 17144784 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin-reuptake inhibitors
Number of subjects: 0
Study 15138667 — intervention group
Group type: EXPERIMENTAL
Intervention: Active vitamin D3 analogues
Number of subjects: 0
Study 11314283 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic and resistance training (AE + R)
Number of subjects: 36
Study 11314283 — intervention group
Group type: COMPARATOR
Intervention: Aerobic training alone (AE)
Number of subjects: 36